Back to results
US 3,937,817 AGranted
Pharmaceutical compositions containing a saccharase inhibitor
AssigneeBayer Aktiengesellschaft
InventorsWerner Frommer, Walter Puls, Delf Schmidt
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeBayer Aktiengesellschaft
InventorsWerner Frommer, Walter Puls, Delf Schmidt
Estimating the term…
The invention relates to a saccharase inhibitor derived from Actinoplanaceae Strain CBS 961.70, including mutants and variants thereof, means for the production of said saccharase inhibitors comprising cultivation of Actinoplanaceae Strain CBS 961.70, including mutants and variants thereof, in appropriate nutrient solutions which are characterized by being starch free under conditions most favorable to growth and production of said saccharase inhibitor and recovering a saccharase inhibitor from culture broths of said nutrient solutions, as well as the use of said inhibitor in pharmaceutically acceptable therapeutic compositions suitable for use in the treatment and relief of conditions indicative of adiposity, diabetes, pre-diabetes, hyperlipaemia (atherosclerosis), caries and the like.
A pharmaceutical composition containing as an active ingredient a therapeutically effective quantity of a saccharase inhibitor mixed with a solid or semi-liquid diluent, wherein said saccharase inhibitor is produced by a method comprising growing Actinoplanaceae strain CBS 961.70 in a starch-free nutrient medium to produce a culture and separating the saccharase inhibitor from the culture.
A pharmaceutical composition containing as an active ingredient a therapeutically effective quantity of a saccharase inhibitor mixed with a solid or semi-liquid diluent, wherein said saccharase inhibitor is produced by a method comprising growing Actinoplanaceae strain CBS 614.71 in a starch-free nutrient medium to produce a culture and separating the saccharase inhibitor from the culture.
Dependencies are inferred from the claim text.